Cell and gene therapy equipment choice can impact the quality of the final drug product. In this session, concrete examples and data will drive a discussion about equipment choice for CGT. We will provide examples of the data you should be asking for from manufacturers before purchasing QC, QA, and process equipment. For instance, design and engineering behind the scenes, as well as features that become more important as your institution grows, will impact your production timelines.
We propose five criteria to evaluate with any lab equipment selection for CGT, including:
Thermo Fisher Scientific's Mary Kay Bates (Senior Global Cell Culture Scientist), Wilfredo Marin (Senior Product Application Specialist Biobanking & Cryopreservation), and Kindra Whitlatch (Product Applications Manager) will share their experiences consulting with cell and gene therapy laboratories on product selection and overcoming challenges with existing manufacturing processes and quality control.